New study questions Type 2 diabetes treatment

CBC reported on the uncertainty that glucose-lowering drugs help ward off long-term complications associated with Type 2 diabetes.

The UBC Therapeutics Initiative is asking Health Canada to demand better evidence that the drugs improve long-term outcomes before they are approved.

“All we truly know is that the drugs reduce blood glucose in the short term. That’s the basis of the evidence. So clinicians and patients are taking a bit of a leap in faith that this will translate into reductions in Type 2 diabetes-related complications,” said Cait O’Sullivan, a member of the Therapeutics Initiative research team.

The story also appeared on Yahoo News.